Canada Viscosupplementation Market is Segmented By Dosage (Single Injection, Three Injection, Five Injection), By Arthritis Type (Osteoarthritis, Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others). The report offers the value (in USD million) for the above-mentioned segments.
Market Size in USD
CAGR7.60%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 7.60% |
Market Concentration | High |
Major Players | Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Sanofi S.A., Anika Therapeutics Inc. |
The Canada Viscosupplementation Market is estimated to be valued at USD 150.8 Mn in 2024 and is expected to reach USD 255.7 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.60% from 2024 to 2031.
Viscosupplementation is a nonsurgical treatment used to treat osteoarthritis by replacing lubricating fluid and restoring synovial viscosity. This treatment method is gaining popularity due to the rising prevalence of osteoarthritis and growing geriatric population.